Canada’s reliance on foreign regulators to inspect drug makers is concerning, say experts
Data obtained by CTV News from Health Canada shows that 85 per cent of inspections of drug manufacturing sites supplying the Canadian market were conducted by international regulators — not Health Canada. And some experts say that's concerning.